Frequency of osteoporosis in 46 men with methamphetamine abuse hospitalized in a National Hospital

Forensic Science International

Volumn 188, Issue 1-3, 2009, Pages 75-80

  Kim, Eun Young ^a   Kwon, Do Hoon ^a   Lee, Byung Dae ^b   Kim, Yang Tae ^a   Ahn, Young Bok ^c   Yoon, Kuee Young ^d   Sa, Sok Jin ^e   Cho, Woong ^a   Cho, Sung Nam ^a  

^a Bugok National Hospital   (South Korea)

^b Pusan National University Hospital   (South Korea)

^c Konkuk University   (South Korea)

^d Osteosys Co   (South Korea)

^e Myungsung Orthopedic Hospital   (South Korea)

Author keywords

Abuse; Addiction; BMD; Korean; Methamphetamine; Osteoporosis

Indexed keywords

METHAMPHETAMINE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; CLINICAL ARTICLE; COMMUNITY HOSPITAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ABUSE; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; LUMBAR SPINE; MALE; MORBIDITY; OSTEOPENIA; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AMPHETAMINE-RELATED DISORDERS; BONE DENSITY; BONE DISEASES, METABOLIC; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; HOSPITALIZATION; HUMANS; KOREA; LUMBAR VERTEBRAE; MALE; METHAMPHETAMINE; MIDDLE AGED; OSTEOPOROSIS;

EID: 67349261701     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2009.03.016     Document Type: Article

References (67)

1. Chung H., Park M., Hahn E., Choi H., and Lim M. Recent trends of drug abuse and drug-associated deaths in Korea. Ann. N. Y. Acad. Sci. 1025 (2004) 458-464
2. McKetin R., Kozel N., Douglas J., Ali R., Vicknasingam B., Lund J., and Li J.H. The rise of methamphetamine in Southeast and East Asia. Drug Alcohol Rev. 27 (2008) 220-228
3. Kulsudjarit K. Drug problem in southeast and southwest Asia. Ann. N. Y. Acad. Sci. 1025 (2004) 446-457
4. Rawson R.A., and Condon T.P. Why do we need an addiction supplement focused on methamphetamine?. Addiction 102 Suppl. 1 (2007) 1-4
5. Lapworth K., Dawe S., Davis P., Kavanagh D., Young R., and Saunders J. Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users. Addict. Behav. (2008)
6. Dore G., and Sweeting M. Drug-induced psychosis associated with crystalline methamphetamine. Aust. Psychiatry 14 (2006) 86-89
7. Zweben J.E., Cohen J.B., Christian D., Galloway G.P., Salinardi M., Parent D., and Iguchi M. Psychiatric symptoms in methamphetamine users. Am. J. Addict. 13 (2004) 181-190
8. Buffenstein A., Heaster J., and Ko P. Chronic psychotic illness from methamphetamine. Am. J. Psychiatry 156 (1999) 662
9. Murray J.B. Psychophysiological aspects of amphetamine-methamphetamine abuse. J. Psychol. 132 (1998) 227-237
10. Miyakawa T., Sumiyoshi S., Deshimaru M., Murayama E., and Tatetsu S. Electron microscopic studies concerning the structural mechanism of the development of mental disturbance in experimental chronic methamphetamine poisoning. Acta Neuropathol. 14 (1969) 215-225
11. Everett H.E. Effect of chronic methamphetamine intoxication in rhesus monkeys. Biol. Psychiatry 3 (1971) 25-32
12. Winslow B.T., Voorhees K.I., and Pehl K.A. Methamphetamine abuse. Am. Fam. Physician 76 (2007) 1169-1174
13. Srikanth S., Barua R., and Ambrose J. Methamphetamine-associated acute left ventricular dysfunction: a variant of stress-induced cardiomyopathy. Cardiology 109 (2008) 188-192
14. Kaye S., McKetin R., Duflou J., and Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 102 (2007) 1204-1211
15. Haning W., and Goebert D. Electrocardiographic abnormalities in methamphetamine abusers. Addiction 102 Suppl. 1 (2007) 70-75
16. Tokunaga I., Kubo S., Ishigami A., Gotohda T., and Kitamura O. Changes in renal function and oxidative damage in methamphetamine-treated rat. Leg. Med. (Tokyo) 8 (2006) 16-21
17. Saito M., Terada M., Kawata T., Ito H., Shigematsu N., Kromkhun P., Yokosuka M., and Saito T.R. Effects of single or repeated administrations of methamphetamine on immune response in mice. Exp. Anim. 57 (2008) 35-43
18. Fumagalli F., Gainetdinov R.R., Valenzano K.J., and Caron M.G. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J. Neurosci. 18 (1998) 4861-4869
19. Rhodus N.L., and Little J.W. Methamphetamine abuse and "meth mouth". Northwest Dent. 84 (2005) 29, 31, 33-7
20. Curtis E.K. Meth mouth: a review of methamphetamine abuse and its oral manifestations. Gen. Dent. 54 (2006) 125-129 (quiz 130)
21. Goodchild J.H., and Donaldson M. Methamphetamine abuse and dentistry: a review of the literature and presentation of a clinical case. Quintessence Int. 38 (2007) 583-590
22. Williams N., and Covington III J.S. Methamphetamine and meth mouth: an overview. J. Tenn. Dent. Assoc. 86 (2006) 32-35
23. Klasser G.D., and Epstein J.B. The methamphetamine epidemic and dentistry. Gen. Dent. 54 (2006) 431-439 (quiz 440, 448)
24. Devlin H., and Horner K. Diagnosis of osteoporosis in oral health care. J. Oral Rehabil. 35 (2008) 152-157
25. Katsuragawa Y. Effect of methamphetamine abuse on the bone quality of the calcaneus. Forensic Sci. Int. 101 (1999) 43-48
26. K.N.S. Office, Census of the Korean population by administrative distinct, sex and age, [Internet]Available from: http://www.kosis.kr/domestic/theme/do01_index.jsp, 2004.
27. Tuck S.P., and Datta H.K. Osteoporosis in the aging male: treatment options. Clin. Interv. Aging 2 (2007) 521-536
28. Krum S.A., Miranda-Carboni G.A., Hauschka P.V., Carroll J.S., Lane T.F., Freedman L.P., and Brown M. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 27 (2008) 535-545
29. Yaegashi Y., Onoda T., Tanno K., Kuribayashi T., Sakata K., and Orimo H. Association of hip fracture incidence and intake of calcium, magnesium, vitamin D, and vitamin K. Eur. J. Epidemiol. 23 (2008) 219-225
30. Mazziotti G., Giustina A., Canalis E., and Bilezikian J.P. Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects. Arq. Bras. Endocrinol. Metabol. 51 (2007) 1404-1412
31. Blahos J. Treatment and prevention of osteoporosis. Wien Med. Wochenschr. 157 (2007) 589-592
32. Migliaccio S., Brama M., Fornari R., Greco E.A., Spera G., and Malavolta N. Glucocorticoid-induced osteoporosis: an osteoblastic disease. Aging Clin. Exp. Res. 19 (2007) 5-10
33. Giro G., Goncalves D., Sakakura C.E., Pereira R.M., Marcantonio Junior E., and Orrico S.R. Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: radiographic study in female rats. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 105 (2008) 162-167
34. Zirngibl R.A., Chan J.S., and Aubin J.E. Estrogen receptor-related receptor alpha (ERRalpha) regulates osteopontin expression through a non-canonical ERRalpha response element in a cell context-dependent manner. J. Mol. Endocrinol. 40 (2008) 61-73
35. Cagnacci A., Bagni B., Zini A., Cannoletta M., Generali M., and Volpe A. Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. Bone 42 (2008) 314-320
36. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth ed. (1994), American Psychiatric Press, Washington, DC
37. Lafleur J., McAdam-Marx C., Kirkness C., and Brixner D.I. Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature (March). Ann. Pharmacother. (2008)
38. Nolla J.M., Roig-Vilaseca D., Gomez-Vaquero C., Mateo L., Juanola X., Rodriguez-Moreno J., Narvaez J., and Valverde J. Frequency of osteoporosis in 187 men with rheumatoid arthritis followed in a university hospital. J. Rheumatol. 33 (2006) 1472-1475
39. World Health Organization, Assessment of fracture risk and its application to screening for postmenopausal osteoporosis, WHO Technical Report Series No. 843. (1994), WHO, Geneva, 1994.
40. Walker J. Osteoporosis: pathogenesis, diagnosis and management. Nurs. Stand. 22 (2008) 48-56 (quiz 58)
41. Lofman O., Hallberg I., Berglund K., Wahlstrom O., Kartous L., Rosenqvist A.M., Larsson L., and Toss G. Women with low-energy fracture should be investigated for osteoporosis. Acta Orthop. 78 (2007) 813-821
42. International Society for Clinical Densitometry. Official positions, [Internet]Available from: http://wwww.iscd.org/Visitors/positions/OfficialPositionsText.cfm., Accessed May 5,2006.
43. Leslie W.D., Adler R.A., El-Hajj Fuleihan G., Hodsman A.B., Kendler D.L., McClung M., Miller P.D., and Watts N.B. Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official Positions. J. Clin. Densitom. 9 (2006) 22-30
44. Takeda S. Osteoporosis: a neuroskeletal disease?. Int. J. Biochem. Cell Biol. 41 (2009) 455-459
45. Wong I.P., Zengin A., Herzog H., and Baldock P.A. Central regulation of bone mass. Semin. Cell Dev. Biol. 19 (2008) 452-458
46. Takeda S. Central control of bone remodelling. J. Neuroendocrinol. 20 (2008) 802-807
47. Chou J., Luo Y., Kuo C.C., Powers K., Shen H., Harvey B.K., Hoffer B.J., and Wang Y. Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents. Neuroscience 151 (2008) 92-103
48. Shen H., Luo Y., Kuo C.C., and Wang Y. BMP7 reduces synergistic injury induced by methamphetamine and ischemia in mouse brain. Neurosci. Lett. 442 (2008) 15-18
49. Mueller K.H., Trias A., and Ray R.D. Bone density and composition. Age-related and pathological changes in water and mineral content. J. Bone Joint Surg. Am. 48 (1966) 140-148
50. Faibish D., Ott S.M., and Boskey A.L. Mineral changes in osteoporosis: a review. Clin. Orthop. Relat. Res. 443 (2006) 28-38
51. Cadet J.L., Jayanthi S., and Deng X. Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Neurotox. Res. 8 (2005) 199-206 (Review)
52. Spreafico A., Frediani B., Francucci C.M., Capperucci C., Chellini F., and Galeazzi M. Role of apoptosis in osteoporosis induced by glucocorticoids. J. Endocrinol. Invest. 31 (2008) 22-27
53. Cadet J.L., Krasnova I.N., Jayanthi S., and Lyles J. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox. Res. 11 (2007) 183-202
54. Vorhees C.V., Reed T.M., Morford L.L., Fukumura M., Wood S.L., Brown C.A., Skelton M.R., McCrea A.E., Rock S.L., and Williams M.T. Periadolescent rats (P41-50) exhibit increased susceptibility to d-methamphetamine-induced long-term spatial and sequential learning deficits compared to juvenile (P21-30 or P31-40) or adult rats (P51-60). Neurotoxicol. Teratol. 27 (2005) 117-134
55. Ago M., Ago K., Hara K., Kashimura S., and Ogata M. Toxicological and histopathological analysis of a patient who died nine days after a single intravenous dose of methamphetamine: a case report. Leg. Med. (Tokyo) 8 (2006) 235-239
56. Karch S.B., Stephens B.G., and Ho C.H. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J. Forensic Sci. 44 (1999) 359-368
57. Nishida N., Ikeda N., Kudo K., and Esaki R. Sudden unexpected death of a methamphetamine abuser with cardiopulmonary abnormalities: a case report. Med. Sci. Law 43 (2003) 267-271
58. Yu Q., Larson D.F., and Watson R.R. Heart disease, methamphetamine and AIDS. Life Sci. 73 (2003) 129-140
59. Anglin M.D., Burke C., Perrochet B., Stamper E., and Dawud-Noursi S. History of the methamphetamine problem. J. Psychoactive Drugs 32 (2000) 137-141
60. Nagata T., Kimura K., Hara K., and Kudo K. Methamphetamine and amphetamine concentrations in postmortem rabbit tissues. Forensic Sci. Int. 48 (1990) 39-47
61. Wang S.M., Lin C.C., Li T.L., Shih C.Y., Giang Y.S., and Liu R.H. Distribution characteristics of methamphetamine and amphetamine in urine and hair specimens collected from alleged methamphetamine users in northern Taiwan. Anal. Chim. Acta 576 (2006) 140-146
62. Lee S., Park Y., Yang W., Han E., Choe S., In S., Lim M., and Chung H. Development of a reference material using methamphetamine abusers' hair samples for the determination of methamphetamine and amphetamine in hair. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 865 (2008) 33-39
63. Gerald M.C., and Hsu S.Y. Effects of methamphetamine on the isolated rat phrenic nerve-diaphragm preparation. Res. Commun. Chem. Pathol. Pharmacol. 10 (1975) 395-398
64. Chenu C. Role of innervation in the control of bone remodeling. J. Musculoskelet. Neuronal. Interact. 4 (2004) 132-134
65. Hou Y.L., Liao E.Y., Wu X.P., Peng Y.Q., Zhang H., Dai R.C., Luo X.H., and Cao X.Z. Effects of the sample size of reference population on determining BMD reference curve and peak BMD and diagnosing osteoporosis. Osteoporos. Int. 19 (2008) 71-78
66. E.M. Kim, M.J. Park, J.S. Lee, H.S. Chung, Y.C. Yoo, J.I. Park, N.K. Sung, Impurity Profiling analysis of Methamphetamine seized in Korea, vol. 33, The Annual Report of National Institute of Scientific Investigation, Ministry of Government Administration and Home Affairs, Seoul, 2001, 244-253.
67. Yacoubian Jr. G.S. Assessing environmental prevention strategies for reducing the prevalence and associated harms of methamphetamine use. J. Drug Educ. 37 (2007) 31-53